Medication info
Aitorin Tablet 10/20

Aitorin Tablet 10/20

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›20mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
White to off-white, bi-convex, rectangular tablet
Packaging
Domestic: 30 tablets (10 tablets/PTP x 3), Export: 30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201007277 · Notified 2010.11.30 · Insurance code 671804920

Summary

Main use
Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia
Who takes it
Adults
Adult dose
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is taken once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg daily. The generally recommended starting dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not suitable. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary and homozygous familial hypercholesterolemia and mixed hyperlipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia.
View approved original text

This medication helps to reduce total cholesterol, LDL cholesterol, ApoB protein, and triglycerides, and to increase HDL cholesterol in patients with primary hypercholesterolemia, particularly in familial and non-familial types, as well as in patients with mixed dyslipidemia. It is also used in patients with homozygous familial hypercholesterolemia when other lipid-lowering treatments are insufficiently effective or inappropriate. This medication is used in conjunction with diet, and is administered when sufficient response is not achieved from dietary adjustments or other non-pharmacological therapies. Before treatment, it is important to identify and manage secondary causes such as diabetes and hypothyroidism, and to monitor treatment progress with regular blood lipid tests. It plays a crucial role in reducing the risk of atherosclerotic vascular disease and helps maintain healthy blood lipid levels. Due to these effects, this medication effectively improves hypercholesterolemia.

How to take

Adult dose

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is taken once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range is 10/10mg~10/40mg daily. The generally recommended starting dose is 10/20mg daily. Patients who require less LDL cholesterol reduction may start at 10/10mg daily. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg once daily in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not suitable. Administration to patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function under Precautions for Use). Administration to patients with renal impairment and patients with chronic kidney disease No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). For patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. Use caution and closely monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is required in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) This medicine should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Precautions

This medication can cause serious muscle-related side effects such as myopathy and rhabdomyolysis, so if muscle pain or weakness occurs during treatment, medical consultation should be sought immediately. The risk of myopathy and rhabdomyolysis may increase especially when this medication is taken at high doses or in conjunction with certain other drugs. This medication should not be administered to patients with hypersensitivity to the ingredients or those with liver dysfunction, as well as to women who are pregnant or breastfeeding. Moreover, it should not be used in combination with strong CYP3A4 inhibitors or certain drugs like gemfibrozil, cyclosporine, and danazol, and attention must be paid to drug interactions. Since this medication may affect liver function, it should be used cautiously in patients with a history of liver disease or abnormal liver function test results. Elderly patients or those at risk of diabetes should be monitored regularly for blood glucose and liver function during treatment. If unexplained muscle pain, tenderness, or weakness occurs, or if symptoms of liver dysfunction appear, immediate medical attention is required. This medication should not be prescribed to women planning to become pregnant; if pregnancy is confirmed, treatment should be stopped immediately. For breastfeeding mothers, it is safer to discontinue breastfeeding while taking this medication. Caution is advised for use in children and adolescents, as safety and efficacy have not been sufficiently confirmed. During treatment with this medication, grapefruit juice and certain other drugs should be avoided, and consulting with healthcare providers before and after medication is essential.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 104 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • joint pain
  • low back pain
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver aminotransferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • sensory abnormality
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • liver damage
  • weakness
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • taste disorder
  • ophthalmoplegia
  • facial incomplete paralysis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • memory decline
  • forgetfulness
  • amnesia
  • memory impairment
  • confusion
  • interstitial lung disease
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • arthritis
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • cholecystic jaundice
  • liver fat changes
  • liver cirrhosis
  • fulminant liver necrosis
  • liver cancer
  • alopecia
  • various skin changes
  • lichenoid drug rash
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ocular muscle paralysis
  • anemia
  • elevated aminotransferases
  • elevated ALP
  • elevated gamma-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • abnormal liver function test
  • increased HbA1c
  • increased fasting blood glucose levels
  • edema
  • thirst
  • facial swelling
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stools
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • weight loss

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture; therefore, it must be stored in a tight container with the lid securely closed when not in use. Additionally, it should be stored at room temperature between 1°C and 30°C, avoiding extremes of temperature.

Appearance and packaging

Appearance

White to off-white, bi-convex, rectangular tablet

Package unit

Domestic: 30 tablets (10 tablets/PTP x 3), Export: 30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.